Teleflex Incorporated Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Teleflex Incorporated inventory turnover ratio, the Teleflex Incorporated's ability to sell and replace its inventory in the first quarter 2026, sequentially increased to 1.4 in the first quarter 2026, yet the ratio remained below the average, as TFX's market remain challenging.Average inventory processing period, for the Teleflex Incorporated in Mar 31 2026 quarter, has decreased to 261 days, compare to 266 days, in the Dec 31 2025 quarter.

Within Healthcare sector 271 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 922 in the fourth quarter 2025, to 1039.

TFX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Teleflex Incorporated Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

TFX Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 28 2025) III. Quarter	(Jun 29 2025) II. Quarter	(Mar 30 2025) I. Quarter
Y / Y Inventory Growth	-40.86 %	-32.62 %	25.4 %	8.91 %	2.57 %
Y / Y Cost of Sales Growth	-22.83 %	-	38.02 %	4.8 %	-3.12 %
Inventory Turnover Ratio (TTM)	1.4	-	2.16	2.09	2.12
TFX's Total Ranking	# 1039	# 922	# 944	# 1189	# 1117
Average inventory processing period	260	-	169	174	172
Seq. Inventory Growth	-5.82 %	-49.61 %	15.68 %	7.72 %	7.3 %
Seq. Cost of Sales Growth	-	-	32.09 %	12.22 %	-12.64 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 124
Healthcare Sector	# 272
Overall Market	# 1039

Inventory Turnover Ratio Statistics
High	Average	Low
2.68	2.36	1.37
(Jul 02 2017)		(Dec 31 2025)

TFX Company Profile >> Back to TFX Efficiency Comparisons >> Compare TFX Inventory Turnover Ratio to its Competitors

Financial Statements
Teleflex Incorporated's Inventories	$ 381 Millions	Visit TFX's Balance sheet
Teleflex Incorporated's Cost of Revenues TTM	$ 800 Millions	Visit TFX's Income Statement
What are TFX's Sales?		Visit TFX's Sales by Segment

Other Inventory Turnover Ratios
Teleflex Incorporated's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TFX's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TFX's Competitors
Inventory Turnover Ratio for TFX's Suppliers
Inventory Turnover Ratio for TFX's Customers

You may also want to know
TFX's Sales Growth Rates	TFX's Pe Price to earnings ratio	TFX's Receivables Turnover Ratio	TFX's Stock Quote
TFX's Net Income Growth Rates	TFX's Ps Price to Sales ratio	TFX's Sales per Employee	TFX's Asset Turnover Ratio
TFX's Net Margin	TFX's Pb Price to Book ratio	TFX's Financial Strength Ratios	TFX's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Transmedics Group Inc	5.71	$ 260.151 Millions	$ 46 Millions
Opko Health Inc	5.69	$ 372.048 Millions	$ 65 Millions
Avantor Inc	5.55	$ 4,447.000 Millions	$ 801 Millions
Steris Plc	5.27	$ 3,309.400 Millions	$ 628 Millions
Bristol myers Squibb Company	5.24	$ 14,324.000 Millions	$ 2,735 Millions
Harrow Inc	5.11	$ 69.568 Millions	$ 14 Millions
Integer Holdings Corporation	5.11	$ 1,365.000 Millions	$ 267 Millions
Tactile Systems Technology Inc	5.08	$ 81.000 Millions	$ 16 Millions
Integrated Biopharma Inc	4.96	$ 45.000 Millions	$ 9 Millions
Ufp Technologies Inc	4.95	$ 436.000 Millions	$ 88 Millions
Polomar Health Services, Inc.	4.79	$ 0.642 Millions	$ 0 Millions
Henry Schein Inc	4.70	$ 9,209.000 Millions	$ 1,959 Millions
Bionexus Gene Lab Corp	4.70	$ 4.191 Millions	$ 1 Millions
Medinotec Inc	4.69	$ 4.864 Millions	$ 1 Millions
West Pharmaceutical Services Inc	4.68	$ 2,052.000 Millions	$ 439 Millions
Scilex Holding Company	4.48	$ 14.462 Millions	$ 3 Millions
Guardant Health Inc	4.41	$ 379.203 Millions	$ 86 Millions
Idexx Laboratories Inc	4.38	$ 1,690.942 Millions	$ 386 Millions
Envista Holdings Corporation	4.36	$ 1,267.000 Millions	$ 290 Millions
Inotiv Inc	4.25	$ 175.895 Millions	$ 41 Millions
Cryoport inc	4.23	$ 96.609 Millions	$ 23 Millions
Teva Pharmaceutical Industries Limited	4.22	$ 8,317.000 Millions	$ 1,971 Millions
Incyte Corporation	4.21	$ 403.465 Millions	$ 96 Millions
Electromed Inc	4.16	$ 14.195 Millions	$ 3 Millions
Vericel Corporation	4.15	$ 73.494 Millions	$ 18 Millions
Sharps Technology Inc	4.12	$ 3.585 Millions	$ 1 Millions
Coherus Oncology inc	4.11	$ 14.975 Millions	$ 4 Millions
Novocure Limited	4.08	$ 167.287 Millions	$ 41 Millions
Lifeward ltd	4.08	$ 13.275 Millions	$ 3 Millions
Ge Healthcare Technologies Inc	4.04	$ 9,262.000 Millions	$ 2,294 Millions

Date modified: 2026-08-30T14:41:14+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.